Anheuser-Busch InBev SA/NV
BUD- Exchange
- NYSE
- Industry
- Malt Beverages
- SEC CIK
- 0001668717
No open-market purchases or sales by Anheuser-Busch InBev SA/NV insiders were filed in the last 90 days; 616 institutions reported holding it in 13F filings for Q2 2026, worth $7.90B in total; superinvestors Gates Foundation Trust and Maverick Capital hold it.
Other share classesBUDFF
13F holders, Q1 2026
Institutional positions in Anheuser-Busch InBev SA/NV as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 549
- +24 vs. Q4 2025
- Shares held
- 92.6M
- −6.98M (−7.0%) vs. Q4 2025
- Total value
- $6.42B
- +$39.9M (+0.6%) vs. Q4 2025
- New holders
- 91
- 195 more added
- Sold out
- 67
- 158 more reduced
10 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BUD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 616 | $7.90B |
| Q1 2026 | 549 | $6.42B |
| Q4 2025 | 535 | $6.38B |
| Q3 2025 | 484 | $6.19B |
| Q2 2025 | 515 | $7.38B |
| Q1 2025 | 498 | $6.80B |
| Q4 2024 | 485 | $5.50B |
| Q3 2024 | 519 | $6.93B |
| Q2 2024 | 509 | $5.95B |
| Q1 2024 | 532 | $6.74B |
| Q4 2023 | 515 | $6.27B |
| Q3 2023 | 479 | $5.27B |
| Q2 2023 | 489 | $5.31B |
| Q1 2023 | 502 | $6.12B |
| Q4 2022 | 511 | $5.86B |
| Q3 2022 | 462 | $4.81B |
| Q2 2022 | 514 | $5.35B |
| Q1 2022 | 506 | $5.33B |
| Q4 2021 | 515 | $4.94B |
| Q3 2021 | 471 | $4.39B |
| Q2 2021 | 528 | $5.30B |
| Q1 2021 | 508 | $4.53B |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Anheuser-Busch InBev SA/NV; share changes are against Q4 2025.